Avidity Biosciences
158 hedge funds and large institutions have $2.28B invested in Avidity Biosciences in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
10% more funds holding
Funds holding: 144 → 158 (+14)
7.56% more ownership
Funds ownership: 104.46% → 112.02% (+7.6%)
2% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 52
Holders
158
Holding in Top 10
7
Calls
$3.06M
Puts
$1.74M
Top Buyers
| 1 | +$97.9M | |
| 2 | +$84.6M | |
| 3 | +$32.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$31M |
| 5 |
O
OrbiMed
New York
|
+$25.4M |
Top Sellers
| 1 | -$36.9M | |
| 2 | -$29.7M | |
| 3 | -$16M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$12.5M |
| 5 |
Two Sigma Investments
New York
|
-$10.7M |